Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8069993 | 0.85 | ALDH1A1 (0.47) | TSHRTDP1ALDH1A1HSD17B10MEN1 | |
| SCHEMBL10980919 | 0.82 | TSHR (0.62) | TSHRTDP1ALDH1A1HSD17B10MAPT | |
| SCHEMBL11047029 | 0.82 | TDP1 (0.53) | TSHRTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL8749133 | 0.80 | ALDH1A1 (0.44) | TSHRTDP1ALDH1A1HSD17B10MEN1 | |
| SCHEMBL31330060 | 0.80 | ALDH1A1 (0.42) | TSHRTDP1ALDH1A1HSD17B10MEN1 | |
| SCHEMBL23152122 | 0.80 | ALDH1A1 (0.44) | TSHRTDP1ALDH1A1HSD17B10MEN1 | |
| SCHEMBL18956810 | 0.80 | MEN1 (0.41) | TSHRTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL240637 | 0.80 | PTGER4 (0.48) | TSHRTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL5704996 | 0.80 | TSHR (0.52) | TSHRTDP1ALDH1A1HSD17B10MEN1 | |
| SCHEMBL27832802 | 0.79 | MEN1 (0.53) | TSHRTDP1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105621587-B | A kind of method using potentiometric titrations degradating chloro nitro-aromatic | 浙江大学 | 2018-01-23 | — | — | CN | claimed |
| CN-105621587-A | Method for degrading chloro-nitroaromatic by using sulfate radicals | UNIV ZHEJIANG | 2016-06-01 | — | — | CN | claimed |
| US-20230234943-A1 | TREX1 INHIBITORS AND USES THEREOF | TEMPEST THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| CN-105621587-B | A kind of method using potentiometric titrations degradating chloro nitro-aromatic | 浙江大学 | 2018-01-23 | — | — | CN | disclosed |
| CN-105621587-A | Method for degrading chloro-nitroaromatic by using sulfate radicals | UNIV ZHEJIANG | 2016-06-01 | — | — | CN | disclosed |
| CN-102086147-B | Preparation method of substituted phenol | LIANHE CHEMICAL TECHNOLOGY CO LTD | 2014-04-09 | — | — | CN | disclosed |
| WO-1992011245-A1 | 2-ACYLAMIDO DERIVATIVES OF 3,4-DIHYDRO-3-OXO-QUINOXALINE HAVING PHARMACEUTICAL ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1992-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234943-A1 | TREX1 INHIBITORS AND USES THEREOF | FEN1, ERCC4, DCLRE1B | TSHR 4029/4885TDP1 28/4885ALDH1A1 1451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.